Janumet Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

HbA1c Variability in Type II Diabetes
Condition:   Diabetes Mellitus Type 2 Interventions:   Drug: Metformin;   Drug: Gliclazide;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Pioglitazone;   Drug: Dapagliflozin;   Drug: human insulin Sponsors:   Weill Cornell Medical College in Qatar;   Hamad Medical Corporation;   Sidra Medical and Research Center;   University of Hull Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2016 Category: Research Source Type: clinical trials

HbA1c Variability in Type II Diabetes
Condition:   Diabetes Mellitus Type 2 Interventions:   Drug: Metformin;   Drug: Gliclazide;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Pioglitazone;   Drug: Dapagliflozin;   Drug: human insulin Sponsors:   Weill Cornell Medical College in Qatar;   Hamad Medical Corporation;   Sidra Medical and Research Center;   University of Hull Not yet recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2016 Category: Research Source Type: clinical trials